Mitochondrial control of the NLRP3 inflammasome
- PMID: 21321591
- DOI: 10.1038/ni0311-199
Mitochondrial control of the NLRP3 inflammasome
Comment on
-
Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome.Nat Immunol. 2011 Mar;12(3):222-30. doi: 10.1038/ni.1980. Epub 2010 Dec 12. Nat Immunol. 2011. PMID: 21151103 Free PMC article.
Similar articles
-
Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.Am J Respir Cell Mol Biol. 2016 Feb;54(2):151-60. doi: 10.1165/rcmb.2015-0231TR. Am J Respir Cell Mol Biol. 2016. PMID: 26418144 Free PMC article. Review.
-
Regulation of adaptive immunity by the NLRP3 inflammasome.Int Immunopharmacol. 2011 May;11(5):549-54. doi: 10.1016/j.intimp.2010.11.025. Epub 2010 Nov 27. Int Immunopharmacol. 2011. PMID: 21118671 Review.
-
Initiation and perpetuation of NLRP3 inflammasome activation and assembly.Immunol Rev. 2015 May;265(1):35-52. doi: 10.1111/imr.12286. Immunol Rev. 2015. PMID: 25879282 Free PMC article. Review.
-
The RIP1-RIP3 complex initiates mitochondrial fission to fuel NLRP3.Nat Immunol. 2014 Dec;15(12):1100-2. doi: 10.1038/ni.3030. Nat Immunol. 2014. PMID: 25396345 Free PMC article.
-
The nucleotide-binding domain, leucine-rich repeat protein 3 inflammasome/IL-1 receptor I axis mediates innate, but not adaptive, immune responses after exposure to particulate matter under 10 μm.Am J Respir Cell Mol Biol. 2015 Jan;52(1):96-105. doi: 10.1165/rcmb.2014-0158OC. Am J Respir Cell Mol Biol. 2015. PMID: 24988285
Cited by
-
Biomedical nanomaterials for immunological applications: ongoing research and clinical trials.Nanoscale Adv. 2020 Aug 24;2(11):5046-5089. doi: 10.1039/d0na00478b. eCollection 2020 Nov 11. Nanoscale Adv. 2020. PMID: 36132021 Free PMC article. Review.
-
Lung Pneumonitis and Fibrosis in Cancer Therapy: A Review on Cellular and Molecular Mechanisms.Curr Drug Targets. 2022;23(16):1505-1525. doi: 10.2174/1389450123666220907144131. Curr Drug Targets. 2022. PMID: 36082868 Review.
-
Does Inflammation Contribute to Cancer Incidence and Mortality during Aging? A Conceptual Review.Cancers (Basel). 2022 Mar 23;14(7):1622. doi: 10.3390/cancers14071622. Cancers (Basel). 2022. PMID: 35406394 Free PMC article. Review.
-
HSPB8 Overexpression Ameliorates Cognitive Impairment in Diabetic Mice via Inhibiting NLRP3 Inflammation Activation.Oxid Med Cell Longev. 2022 Aug 1;2022:9251835. doi: 10.1155/2022/9251835. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35958024 Free PMC article.
-
Exploring Candesartan, an angiotensin II receptor antagonist, as a novel inhibitor of NLRP3 inflammasome: alleviating inflammation in Neisseria gonorrhoeae infection.BMC Infect Dis. 2024 Nov 22;24(1):1338. doi: 10.1186/s12879-024-10208-3. BMC Infect Dis. 2024. PMID: 39578786 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources